4//SEC Filing
Dhaliwal Harpreet S. 4
Accession 0001209191-22-062992
CIK 0001649094other
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 4:28 PM ET
Size
7.3 KB
Accession
0001209191-22-062992
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Dhaliwal Harpreet S.
Chief Technical Ops Officer
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2022-12-28+3,990→ 96,010 totalExercise: $25.06Exp: 2031-11-07→ Common Stock (3,990 underlying) - Exercise/Conversion
Common Stock
2022-12-28$25.06/sh+3,990$99,989→ 21,808 total
Footnotes (2)
- [F1]Includes 928 shares acquired under the Vaxcyte, Inc. Employee Stock Purchase Plan on November 17, 2022.
- [F2]1/48 of shares subject to the option vest on January 30, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date.
Documents
Issuer
Vaxcyte, Inc.
CIK 0001649094
Entity typeother
Related Parties
1- filerCIK 0001886794
Filing Metadata
- Form type
- 4
- Filed
- Dec 29, 7:00 PM ET
- Accepted
- Dec 30, 4:28 PM ET
- Size
- 7.3 KB